← Back to Glutathione product page
Glutathione-Related Processes in Antioxidant Defense
Cnubben et al. (2001) published a comprehensive review of glutathione-associated cellular processes that play a central role in defense against oxidative stress. The review demonstrated that GSH itself is a critical factor in maintaining the cellular redox balance and is directly involved in regulation of cell signaling and repair pathways. Enhanced expression of various enzymes involved in GSH metabolism — including glutathione peroxidases, γ-glutamyl cysteinyl synthetase (γ-GCS), glutathione S-transferases (GST), and ATP-binding cassette family membrane proteins — all play prominent roles in cellular resistance to oxidative stress. The authors emphasized that a coordinated interplay between these systems is essential for efficient protection.
Citation: Cnubben NHP, Rietjens IMCM, Wortelboer H, van Zanden J, van Bladeren PJ. The interplay of glutathione-related processes in antioxidant defense. Environ Toxicol Pharmacol. 2001;10(4):141-152. doi:10.1016/S1382-6689(01)00077-1. PubMed PMID: 21782570
Glutathione, Oxidative Stress, and Neurodegeneration
Schulz et al. (2000) reviewed the evidence for disturbances in glutathione homeostasis that may either lead to or result from oxidative stress in neurodegenerative disorders. The review examined significant evidence that the pathogenesis of Parkinson’s disease, Alzheimer’s disease, Friedreich’s ataxia, and amyotrophic lateral sclerosis may involve the generation of reactive oxygen species (ROS) and mitochondrial dysfunction. A particularly important finding was that decreased total glutathione concentrations in the substantia nigra have been observed in preclinical stages of Parkinson’s disease, at a time when other biochemical changes are not yet detectable. The authors discussed treatment strategies to increase brain GSH concentrations, including glutathione analogs, mimetics, and precursors.
Citation: Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem. 2000;267(16):4904-4911. doi:10.1046/j.1432-1327.2000.01595.x. PubMed PMID: 10931172
Glutathione and Immune Function
Dröge and Breitkreutz (2000) reviewed the relationship between glutathione and immune function, demonstrating that the immune system works optimally when lymphoid cells maintain a delicately balanced intermediate level of glutathione. Even moderate changes in the intracellular GSH level have profound effects on lymphocyte functions, with the DNA synthetic response being exquisitely sensitive to reactive oxygen intermediates and therefore to changes in GSH levels. The review detailed how GSH depletion impairs T-cell proliferation, natural killer cell activity, and cytokine production, while GSH supplementation can enhance these immune parameters in models of immunodeficiency.
Citation: Dröge W, Breitkreutz R. Glutathione and immune function. Proc Nutr Soc. 2000;59(4):595-600. doi:10.1017/S0029665100000847. PubMed PMID: 11115795
Randomized Controlled Trial of Oral Glutathione Supplementation
Richie et al. (2015) conducted a randomized, double-blind, placebo-controlled trial to evaluate the effects of oral glutathione supplementation on body stores of GSH in healthy adults. While oral GSH had been shown to be bioavailable in laboratory animal models, its efficacy in humans had not been established. The trial demonstrated that oral GSH supplementation at doses of 250 mg/day and 1000 mg/day for 6 months resulted in significant increases in GSH levels in blood, buccal cells, and erythrocytes. The higher dose produced greater increases. Additionally, natural killer (NK) cell cytotoxicity increased more than two-fold in the high-dose group, suggesting immune-enhancing effects of GSH supplementation.
Citation: Richie JP Jr, Nichenametla S, Neiber W, Calcagnotto A, Haley JS, Schell TD, Muscat JE. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263. doi:10.1007/s00394-014-0706-z. PubMed PMID: 24791752
Liposomal Glutathione Elevates Body Stores and Markers of Immune Function
Sinha et al. (2018) investigated the effects of oral supplementation with liposomal glutathione on GSH body stores and immune function markers. The study found that daily liposomal GSH administration was effective at elevating stores of GSH in blood and immune function markers. Participants receiving liposomal GSH showed significant increases in erythrocyte and plasma GSH levels, reduced oxidative stress markers (8-isoprostane), and enhanced immune function as measured by NK cell cytotoxicity and lymphocyte proliferation. The liposomal delivery form demonstrated improved bioavailability compared to non-liposomal oral GSH, supporting the effectiveness of this delivery approach for raising tissue glutathione levels.
Citation: Sinha R, Sinha I, Calcagnotto A, Trushin N, Haley JS, Schell TD, Richie JP Jr. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2018;72(1):105-111. doi:10.1038/ejcn.2017.132. PubMed PMID: 28853742
Reviewed for scientific accuracy — Chameleon Peptides Research Team. Last reviewed: March 2026.